![Targeting mTOR for the treatment of B cell malignancies - Lee - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library Targeting mTOR for the treatment of B cell malignancies - Lee - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/bcd44c84-0aa8-4f24-829a-b0356f1530ce/bcp12888-fig-0003-m.jpg)
Targeting mTOR for the treatment of B cell malignancies - Lee - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library
![Frontiers | Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2 | Genetics Frontiers | Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2 | Genetics](https://www.frontiersin.org/files/Articles/31792/fgene-03-00177-HTML/image_m/fgene-03-00177-g001.jpg)
Frontiers | Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2 | Genetics
![The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation - Kidney International The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2043418334/2055984853/gr1.jpg)
The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation - Kidney International
![Mechanism of action of sirolimus. Multiple downstream targets of the... | Download Scientific Diagram Mechanism of action of sirolimus. Multiple downstream targets of the... | Download Scientific Diagram](https://www.researchgate.net/profile/Joseph-Antin-2/publication/8435451/figure/fig1/AS:267425200513030@1440770544712/Mechanism-of-action-of-sirolimus-Multiple-downstream-targets-of-the.png)
Mechanism of action of sirolimus. Multiple downstream targets of the... | Download Scientific Diagram
![Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology - Journal of the American Academy of Dermatology Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/09c3a59e-67d5-4127-a702-37e53908c078/gr1_lrg.jpg)
Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology - Journal of the American Academy of Dermatology
![Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram](https://www.researchgate.net/profile/Joelle-Collignon/publication/262384115/figure/fig1/AS:203015328931840@1425414034127/Mechanism-of-action-of-different-classes-of-mTOR-inhibitors-rapalogs-already-approved.png)
Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram
![Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen](https://www.intechopen.com/media/chapter/62579/media/F1.png)
Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen
![mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression - Kidney International mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2043419410/2055988451/gr1.jpg)
mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression - Kidney International
![Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy | SpringerLink Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10286-019-00662-4/MediaObjects/10286_2019_662_Fig1_HTML.png)
Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy | SpringerLink
![mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13578-020-00396-1/MediaObjects/13578_2020_396_Fig1_HTML.png)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text
![mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13578-020-00396-1/MediaObjects/13578_2020_396_Fig2_HTML.png)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text
![Frontiers | Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application | Pharmacology Frontiers | Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application | Pharmacology](https://www.frontiersin.org/files/Articles/429744/fphar-09-01520-HTML/image_m/fphar-09-01520-g001.jpg)